News
-
-
-
PRESS RELEASE
Euronext announces the success of its offering of bonds due 2032 convertible into new shares and/or exchangeable for existing shares (“OCEANEs”) for a nominal amount of €425 million
Euronext successfully completes offering of €425 million bonds due 2032 convertible into new or existing shares. Bonds pay 1.50% fixed coupon and initial conversion price set at €191.1654 -
-
PRESS RELEASE
COOFANDY Marks 10th Anniversary with Dual Silver Awards at Berlin and New York Product Design Competitions
COOFANDY Men's Short-Sleeve Casual Shirts receive Silver Awards at 2025 Berlin Design Awards and New York Product Design Awards, showcasing brand's design prowess and commitment to quality and sustainability -
-
PRESS RELEASE
Transgene to Present 24-month Disease-Free Survival Data from All Patients in Phase I Part of Trial of Individualized Cancer Vaccine, TG4050, at ASCO 2025
Transgene to present 24-month disease-free survival data from all patients in Phase I part of trial of individualized cancer vaccine, TG4050, at ASCO 2025 -
-
PRESS RELEASE
VALBIOTIS SA: Valbiotis to launch ValbiotisPRO® Cardio-circulation on 2 June
Valbiotis announces the launch of ValbiotisPRO® Cardio-circulation on 2 June, expanding its range of scientifically tested dietary supplements to support cardiometabolic balance. Multichannel marketing strategy accelerates with listings in supplemental insurance companies -
